Literature DB >> 24691300

What are the predictors of major depression in adult patients with epilepsy?

Chen Kui1, Pan Yingfu1, Xu Chenling1, Wu Wenqing1, Li Xiuhua1, Sun Di1.   

Abstract

Epilepsy is not only a chronic neurological disorder but also a condition associated with other comorbidities. The purpose of this study was to determine the prevalence of major depression in a cohort of adult patients with epilepsy (PWEs) living in north China, and investigate the predictors of major depression in PWEs. A total of 215 consecutive cases were enrolled and divided into two groups: PWEs with major depression and PWEs without major depression. Patients were assessed for demographic characteristics, epilepsy details, and social status. A total of 65 of 215 (30.23%) PWEs exhibited comorbid major depression. A binary logistic regression model revealed the strong predictor variables of major depression to be drug responsiveness (odds ratio [OR]=0.23; p=0<0.01; 95% CI [0.13-0.39]), presence of chronic medical illnesses (OR=0.19; p=0.015<0.05; 95% CI [0.05-0.72]), and employment status (OR=0.42; p=0.015<0.05; 95% CI [0.21-0.84]).

Entities:  

Keywords:  China; chronic illness; depression; drug responsiveness; epilepsy; predictor; social status

Mesh:

Year:  2014        PMID: 24691300     DOI: 10.1684/epd.2014.0634

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  2 in total

1.  An investigation into the psychosocial effects of the postictal state.

Authors:  Colin B Josephson; Jordan D T Engbers; Tolulope T Sajobi; Nathalie Jette; Yahya Agha-Khani; Paolo Federico; William Murphy; Neelan Pillay; Samuel Wiebe
Journal:  Neurology       Date:  2016-01-27       Impact factor: 9.910

2.  Depressogenic medications and other risk factors for depression among Polish patients with epilepsy.

Authors:  Magdalena Bosak; Wojciech Turaj; Dominika Dudek; Marcin Siwek; Andrzej Szczudlik
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-30       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.